Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast Track status and solid cash reserves, investor optimism builds. ...

DocGo buys virtual care platform SteadyMD in an all-cash deal, boosting its digital health reach. The move excites investors as DocGo gains growth, profit potential, and key new leadership. ...

Novavax faces pressure from a major shareholder Shah Capital to explore a sale as it struggles with weak revenue, poor execution, and fading relevance post-COVID-19. ...

Mister Car Wash expands in Texas with five new Whistle Express locations, strengthening its local network, boosting efficiency, and focusing on smarter, more strategic long-term growth. ...

IBM shares took a dive on Thursday despite stronger-than-expected third-quarter earnings and revenue. Investors have turned their focus to signs of cooling growth in the company’s software and hybrid cloud ...

U.S. stocks rose on Thursday, fueled by a rebound in oil prices and fresh corporate earnings. ...

McEwen Mining is acquiring Canadian Gold Corp. in an all-stock deal, adding the high-grade Tartan Lake project in Manitoba to its portfolio—a strategic move to boost output and advance its ...

ChatGPT said: Talkspace acquires Wisdo Health to strengthen its AI-driven behavioral health platform, adding peer-based support and expanding reach across major healthcare markets. ...

Retail traders are back in force, and so are meme stocks. Shares of several heavily shorted, high-volatility names surged this week as investors piled into speculative trades reminiscent of the ...

U.S. stocks took a hit on Wednesday, with tech stocks leading the decline while the broader market awaited earnings reports from Tesla, Inc., and IBM. ...

The U.S. rare earths sector is suddenly back in focus as investors rush to find the next big play in critical minerals. ...

Jack in the Box shares plunged after selling Del Taco for just $115 million—an 80% markdown from its 2021 purchase—raising investor doubts about its strategy and deepening its 2025 slump. ...